Marketing-authorisation holder Β· Canada
Pegasus Laboratories Inc
7 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
7 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| PROIN CHEWABLE TABLETS50 mg Β· Tablet | Phenylpropanolamine | Canada | Marketed | 2013 |
| PROIN CHEWABLE TABLETS75 mg Β· Tablet | Phenylpropanolamine | Canada | Marketed | 2013 |
| PROIN CHEWABLE TABLETS25 mg Β· Tablet | Phenylpropanolamine | Canada | Marketed | 2013 |
| RECONCILE8 mg Β· Tablet (Chewable) | Fluoxetine | Canada | Marketed | 2010 |
| RECONCILE32 mg Β· Tablet (Chewable) | Fluoxetine | Canada | Marketed | 2010 |
| RECONCILE16 mg Β· Tablet (Chewable) | Fluoxetine | Canada | Marketed | 2010 |
| RECONCILE64 mg Β· Tablet (Chewable) | Fluoxetine | Canada | Marketed | 2010 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines |
|---|



